These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6987254)

  • 21. [Somatomedin following administration of growth hormone in pituitary dwarfism].
    Marek J; Kopecký A; Schüllerová M; Schreiberová O
    Cesk Pediatr; 1978 Oct; 33(10):582-6. PubMed ID: 729059
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolactin and somatomedin in hypopituitary patients with "catch up" growth following operations for craniopharyngioma.
    Kenny FM; Guyda HJ; Wright JC; Friesen HG
    J Clin Endocrinol Metab; 1973 Feb; 36(2):378-80. PubMed ID: 4683190
    [No Abstract]   [Full Text] [Related]  

  • 23. Relation between growth hormone and somatomedin.
    Van Wyk JJ; Underwood LE
    Annu Rev Med; 1975; 26():427-41. PubMed ID: 167653
    [No Abstract]   [Full Text] [Related]  

  • 24. Receptor-active growth hormone in Laron dwarfism.
    Jacobs LS; Sneid DS; Garland JT; Laron Z; Daughaday WH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):403-6. PubMed ID: 177445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activity of blood somatomedin during childhood in normal subjects and in delayed growth].
    Pierson M; Grignon G; Malaprade D; Hartemann P
    Ann Biol Clin (Paris); 1976; 34(1):11-8. PubMed ID: 970694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Severe dwarfism with high plasma hGH levels and no somatomedin acitvity: Laron's syndrome (author's transl)].
    Mariani P; Gourmelen M; Carnot JF; Saignes F; Cayroche P
    Sem Hop; 1980 Nov 18-25; 56(43-44):1853-6. PubMed ID: 6256891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal regulation of growth by somatomedin and other tissue growth factors.
    Daughaday WH
    Clin Endocrinol Metab; 1977 Mar; 6(1):117-35. PubMed ID: 330030
    [No Abstract]   [Full Text] [Related]  

  • 28. [Somatomedins and their significance in pediatrics].
    Vetter U; Teller WM
    Klin Padiatr; 1985; 197(5):378-85. PubMed ID: 3906254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone levels during sleep in normal and growth hormone deficient children.
    Underwood LE; Azumi K; Voina SJ; Van Wyk JJ
    Pediatrics; 1971 Dec; 48(6):946-54. PubMed ID: 5129454
    [No Abstract]   [Full Text] [Related]  

  • 30. Modulation of homologous receptor concentrations: a sensitive radioassay for human growth hormone in acromegalic, newborn, and stimulated plasma.
    Rosenfeld RG; Hintz RL
    J Clin Endocrinol Metab; 1980 Jan; 50(1):62-9. PubMed ID: 6243134
    [No Abstract]   [Full Text] [Related]  

  • 31. Growth hormone assessment by radioreceptor and radioimmunoassay. Radioreceptor assay and radioimmunoassay comparisons.
    LaFranchi S; Hanna CE; Jelen B
    Am J Dis Child; 1984 Jan; 138(1):23-7. PubMed ID: 6537873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Information supplied by the radio-immunologic determination of the plasma somatotropic hormone during fasting and after administration of insulin, arginine and glucose per os in 14 cases of nanism in child. Demonstration of an isolated somatotropin deficiency in 2 cases].
    Josso N; Rosselin G; Tchobroutsky G; Balsan S
    Arch Fr Pediatr; 1969 May; 26(5):507-21. PubMed ID: 4312139
    [No Abstract]   [Full Text] [Related]  

  • 33. [Functional exploration of the somatotropic activity of the pituitary gland by means of arginine-insulin load. Studies on "harmonic" nanisms with special reference to patients with intermedial somatotropin values].
    Gaburro D; Zoppi G
    Minerva Pediatr; 1976 May; 28(17):1035-41. PubMed ID: 1012171
    [No Abstract]   [Full Text] [Related]  

  • 34. Laron's dwarfism: studies on the nature of the defect.
    Elders MJ; Garland JT; Daughaday WA; Fisher DA; Whitney JE; Hughes ER
    J Pediatr; 1973 Aug; 83(2):253-63. PubMed ID: 4717582
    [No Abstract]   [Full Text] [Related]  

  • 35. The 20,000-dalton variant of human growth hormone: effect on bioassayable somatomedin activity in serum.
    Mosier HD; Lewis UJ
    Horm Metab Res; 1982 Aug; 14(8):440-1. PubMed ID: 7129355
    [No Abstract]   [Full Text] [Related]  

  • 36. Increasing growth with raised circulating somatomedin but normal immunoassayable growth hormone.
    Hoffenberg R; Howell A; Epstein S; Pimstone BL; Fryklund L; Hall K; Schwalbe S; Rudd BT
    Clin Endocrinol (Oxf); 1977 Jun; 6(6):443-8. PubMed ID: 884876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Behavior of the somatotropic hormone and of somatomedin (sulfation factor) in achondroplasia].
    Isidori A; Cianfriglia F; Dondero F
    Folia Endocrinol; 1974 Apr; 27(2):179-84. PubMed ID: 4406489
    [No Abstract]   [Full Text] [Related]  

  • 38. Somatomedins.
    Stuart MC; Lazarus L
    Med J Aust; 1975 Jun; 1(26):816-20. PubMed ID: 1152775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of rat age on serum levels of growth hormone and somatomedins.
    Florini JR; Harned JA; Richman RA; Weiss JP
    Mech Ageing Dev; 1981 Feb; 15(2):165-76. PubMed ID: 7194952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between somatomedin A in serum and body height development in healthy children and children with certain growth disturbances.
    Hall K; Filipsson R
    Acta Endocrinol (Copenh); 1975 Feb; 78(2):239-50. PubMed ID: 1172897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.